Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Like
Tweet
Print
Solaiman Alhawas
Saudi Food & Drug Authority (SFDA), Saudi Arabia
Poster(s):
(031) Proactive Safety Monitoring of Recent Registered Medicinal Products in Saudi Arabia: the SFDA Experience
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
(316) Potential Association of Syndrome of Inappropriate Antidiuretic Hormone Secretion with Olanzapine Use
Monday, August 26, 2024
8:00 AM – 6:00 PM
CEST
(CSPOT45) Post-marketing Safety Assessment of CAR T-cell Therapies: Analysis of Individual Case Safety Reports in the VigiBase
Wednesday, August 28, 2024
8:00 AM – 1:30 PM
CEST
